Séverine Thomas is a Senior Engineer in Analytical Research and Development at Cellectis, bringing 18 years of experience in cellular biology, immunotherapy, and molecular biology. After early experiences at Sanofi Pasteur and Merck Health, Séverine spent 16 years at Cellectis, where they developed and validated various nucleases and led functional studies of UCART22 cells, which received FDA approval in June 2018. Currently, they focus on developing and validating reference cell lines essential for testing UCART products and raw materials. Séverine's work is characterized by a strong collaborative approach and proficiency in advanced analytical techniques.
This person is not in the org chart
This person is not in any teams
This person is not in any offices